Dermatologic Manifestations of Multiple Endocrine Neoplasia Type 1 (MEN1) Questions & Answers

Updated: Sep 14, 2018
  • Author: Thomas N Darling, MD, PhD; Chief Editor: Dirk M Elston, MD  more...
  • Print
Questions & Answers

Overview

What multiple endocrine neoplasia type 1 (MEN1)?

What is the pathophysiology of multiple endocrine neoplasia type 1 (MEN1)

What is the prevalence of multiple endocrine neoplasia type 1 (MEN1)?

Which patient groups have the highest prevalence of multiple endocrine neoplasia type 1 (MEN1)?

Which age group has the highest prevalence of multiple endocrine neoplasia type 1 (MEN1) endocrine tumors?

Which age group has the highest prevalence of multiple endocrine neoplasia type 1 (MEN1) cutaneous tumors?

What is the morbidity and mortality associated with multiple endocrine neoplasia type 1 (MEN1)?

Presentation

Which clinical history findings are characteristic of cutaneous tumors in multiple endocrine neoplasia type 1 (MEN1)?

Which physical findings are characteristic of multiple endocrine neoplasia type 1 (MEN1)?

DDX

What are the differential diagnoses for Dermatologic Manifestations of Multiple Endocrine Neoplasia Type 1 (MEN1)?

Workup

What is the role of lab tests in the diagnosis of multiple endocrine neoplasia type 1 (MEN1)?

What is the role of biopsy in the workup of multiple endocrine neoplasia type 1 (MEN1)?

Which histologic findings are characteristic of multiple endocrine neoplasia type 1 (MEN1)?

What is the role of imaging studies in the workup of multiple endocrine neoplasia type 1 (MEN1)?

Treatment

Which organizations have published guidelines on the treatment of multiple endocrine neoplasia type 1 (MEN1)?

What is the role of surgery in the treatment of multiple endocrine neoplasia type 1 (MEN1)?

Which specialist consultations are beneficial to patients with multiple endocrine neoplasia type 1 (MEN1)?

Follow-up

What are the possible complications of multiple endocrine neoplasia type 1 (MEN1) endocrine tumors?

What are the possible complications of multiple endocrine neoplasia type 1 (MEN1) cutaneous tumors?